Regeneron Pharmaceuticals | REGN - Nettoeinkommen





Nettoeinkommen Veränderung Datum
AbbVie USD 4.22B 605M 2026-09
Agenus USD 39.17M 49.8M 2026-03
Agios Pharmaceuticals USD -100.7M 1.59M 2026-06
Alnylam Pharmaceuticals USD 2.17B 2B 2026-09
Amgen USD 3.86B 1.49B 2026-09
Astellas Pharma JPY 99.85B 41.98B 2026-09
AstraZeneca USD 3.12B 610M 2026-09
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD -122.83M 167.59M 2026-09
Bristol-Myers Squibb USD 2.16B 1.16B 2026-09
Eli Lilly USD 7.1B 301M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Incyte USD -784.8M 1.37B 2026-09
Ionis Pharmaceuticals USD -87M 27.65M 2026-09
J&J USD 210M 5.32B 2026-09
Kyowa Hakko Kirin JPY 21.06B 2.47B 2026-09
Merck USD 5.07B 6.4B 2026-09
Moderna USD 162M 944M 2026-09
Neurocrine Biosciences USD 206.5M 62.1M 2026-09
Novartis USD 1.2B 2.06B 2026-09
Novartis USD 1.2B 1.95B 2026-09
Pfizer USD 3.24B 3.49B 2026-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Sarepta Therapeutics USD -28.46M 23.57M 2026-09
Teva Pharmaceutical Industries USD 233M 809M 2026-09
Ultragenyx Pharmaceutical USD -118M 26M 2026-09
United Therapeutics USD 258.6M 74.4M 2026-09
Vertex Pharmaceuticals USD 653.6M 446.2M 2026-09